Hanmi Pharmaceutical Company Limited
Clinical trials sponsored by Hanmi Pharmaceutical Company Limited, explained in plain language.
-
New combo therapy shows promise for tough stomach cancers
Disease control CompletedThis study tested a new drug (FLX475) combined with an immunotherapy (pembrolizumab) in 20 people with advanced or metastatic stomach cancer. The goal was to see if the combination could shrink tumors. Participants had already tried other treatments without success. The study is …
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New painkiller goes head-to-head with standard treatment for back pain sufferers
Symptom relief CompletedThis study tested a new pain medication called HCP1004 against an existing one (RLD2401) in 310 adults with chronic low-back pain lasting at least 3 months. The goal was to see if the new drug works just as well and is safe. Participants rated their pain using a scale, and resear…
Phase: PHASE3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC